CN102464676B - Ruthenium (II)-polypyridine complex, and preparation method and application thereof - Google Patents

Ruthenium (II)-polypyridine complex, and preparation method and application thereof Download PDF

Info

Publication number
CN102464676B
CN102464676B CN201010533717.4A CN201010533717A CN102464676B CN 102464676 B CN102464676 B CN 102464676B CN 201010533717 A CN201010533717 A CN 201010533717A CN 102464676 B CN102464676 B CN 102464676B
Authority
CN
China
Prior art keywords
ruthenium
dppzi
bpy
phen
imidazoles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201010533717.4A
Other languages
Chinese (zh)
Other versions
CN102464676A (en
Inventor
赵娟
石硕
姚天明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tongji University
Original Assignee
Tongji University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tongji University filed Critical Tongji University
Priority to CN201010533717.4A priority Critical patent/CN102464676B/en
Publication of CN102464676A publication Critical patent/CN102464676A/en
Application granted granted Critical
Publication of CN102464676B publication Critical patent/CN102464676B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B17/00Azine dyes
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B57/00Other synthetic dyes of known constitution
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B57/00Other synthetic dyes of known constitution
    • C09B57/10Metal complexes of organic compounds not being dyes in uncomplexed form
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pyridine Compounds (AREA)

Abstract

The invention provides a ruthenium (II)-polypyridine complex. For the ruthenium (II)-polypyridine complex, bipyridyl (bpy) or phenanthroline hydrate (phen) is used as an ancillary ligand, and dipyridine[3,2-a:2',3'-c]phenazine-11,12-imidazole (dppzi) is used as a main ligand. The preparation method comprises the following steps: preparing 5,6-dinitrobenzimidazole from 5,6-nitrobenzimidazole; reducing 5,6-dinitrobenzimidazole into 5,6-diaminobenzimidazole by using hydrazine hydrate and palladium/carbon; preparing dppzi from phenanthroline hydrate-5,6-dione and 5,6-diaminobenzimidazole and preparing cis-[Ru(bpy)2Cl2].2H2O from ruthenium trichloride, bpy and lithium chloride; preparing cis-[Ru(phen)2Cl2].3H2O from ruthenium trichloride, phen and lithium chloride; carrying out a heating reflux reaction on dppzi and cis-[Ru(bpy)2Cl2].2H2O or cis-[Ru(phen)2Cl2].3H2O under the protection of argon, carrying out cooling, adding ammonium hexafluorophosphate, allowing precipitate to deposit and carrying out filtration and column chromatography so as to obtain a target product. The ruthenium (II)-polypyridine complex provided in the invention can be used as an optical switch for G-quadruplex DNA molecules.

Description

Ruthenium (II) multi-pyridine ligand and its preparation method and application
Technical field
The present invention relates to metal complexes, be specifically related to a kind of ruthenium (II) multi-pyridine ligand and its preparation method and application.
Background technology
Ruthenium outermost layer has 4d 75s 1structure, its common valence state is Ru (I), Ru (II) and Ru (III), and is easy to form the title complex of hexa-coordinate.Transition metal ruthenium (II) multi-pyridine ligand has unique DNA binding ability, good electrochemistry, photochemistry, Photophysics and abundant fluorescent property, and there is hypotoxicity, the feature that easily absorbs and easily drain.The aspects such as charge transfer, DNA footprint reagent, DNA break reagent and anticarcinogen at DNA structure probe, DNA have a wide range of applications, and have caused widely and have paid close attention to, and become very active forward position and crossing domain.[1] the particularly discovery of DNA-molecular light switch ruthenium complexe, causes the concern that people are larger.These title complexs in water, do not have or fluorescence very weak, but in aqueous dna, there is strong fluorescent emission, so these title complexs are called DNA-molecular light switch title complex.[2,3] are well-known, [Ru (phen) 2dppz] 2+[Ru (bpy) 2dppz] 2+the extensive good DNA molecular photoswitch title complex of approval, however the large quantity research of relative engagement thing and double-stranded DNA bonding, and [Ru(bpy)2(dppzi) is as G-tetra-serobila DNA molecular photoswitches rarely seen report also.
Summary of the invention
Object of the present invention, exactly for provide a kind of can be as ruthenium (II) multi-pyridine ligand of G-tetra-serobila DNA molecular photoswitches and preparation method thereof.
In order to achieve the above object, the present invention has adopted following technical scheme: a kind of ruthenium (II) multi-pyridine ligand, be characterized in, described ruthenium (II) multi-pyridine ligand is with two pyridines [3,2-a:2 ', 3 '-c] and azophenlyene-11,12-imidazoles is main part, using dipyridyl or phenanthroline as ruthenium (II) title complex of assistant ligand, and the chemical formula of this ruthenium (II) multi-pyridine ligand is [Ru (bpy) 2dppzi] (PF 6) 2or [Ru (phen) 2dppzi] (PF 6) 2, wherein, [Ru (bpy) 2dppzi] (PF 6) 2following (1) formula of structural formula shown in, [Ru (phen) 2dppzi] (PF 6) 2shown in following (2) formula of structural formula;
Figure GDA0000388279660000022
Bpy represents dipyridyl, and phen represents phenanthroline, and dppzi represents two pyridines [3,2-a:2 ', 3 '-c] azophenlyene-11,12-imidazoles.
The preparation method of above-mentioned ruthenium (II) multi-pyridine ligand, comprises the following steps:
1) 5,6-dinitrobenzene benzo imidazoles synthetic
By 5-nitrobenzimidazole reacting by heating under the vitriol oil and nitrosonitric acid environment, cooling rear with sodium hydroxide neutralization, prepare 5,6-dinitrobenzene benzo imidazoles;
2) 5,6-diamino benzo imidazoles synthetic
By step 1) gained 5,6-dinitrobenzene benzo imidazoles is usingd palladium carbon as catalyzer, usings hydrazine hydrate as reductive agent, usings ethanol as solvent, under argon shield, reacts, and reaction product activated carbon decolorizing, filters, and prepares 5,6-diamino benzo imidazoles;
3) phenanthroline-5,6-diketone synthetic
With phenanthroline and Potassium Bromide, under the effect of vitriol oil concentrated nitric acid, prepare phenanthroline-5,6-diketone;
4) two pyridines [3,2-a:2 ', 3 '-c] azophenlyene-11, the main part of 12-imidazoles synthetic
By phenanthroline-5,6-diketone and 5,6-dinitrobenzene benzo imidazoles, with the mixed in molar ratio of 1:1, add methyl alcohol or ethanol as solvent, and reflux is prepared two pyridines [3,2-a:2 ', 3 '-c] azophenlyene-11, the main part of 12-imidazoles;
5) cis-[Ru (bpy) 2cl 2] .2H 2o's is synthetic
Use RuCl 3, dipyridyl and lithium chloride in DMF, reflux under argon shield, adds acetone after cooling, prepares cis-[Ru (bpy) 2cl 2] .2H 2o;
6) cis-[Ru (phen) 2cl 2] .3H 2o's is synthetic
Use RuCl 3, phenanthroline and lithium chloride in DMF, argon shield reflux, adds acetone after cooling, prepares cis-[Ru (phen) 2cl 2] .3H 2o;
7) [Ru (bpy) 2dppzi] (PF 6) 2synthetic
By cis-[Ru (bpy) 2cl 2] .2H 2o and two pyridines [3,2-a:2 ', 3 '-c] azophenlyene-11,12-imidazoles, with the mixed in molar ratio of 1:1, adds ethylene glycol, at argon shield and 120 ℃, reacts 6h, and cooling, thin up, adds NH 4pF 6saturated solution, obtains red precipitate, suction filtration, and water and ether washing precipitation, will precipitate and be dried, and with acetonitrile, dissolve, and use neutral alumina column chromatography for separation, by main red part under eluent wash-out, boil off solvent, obtain red powder for [Ru (bpy) 2dppzi] (PF 6) 2product;
8) [Ru (phen) 2dppzi] (PF 6) 2synthetic
By cis-[Ru (phen) 2cl 2] .3H 2o and two pyridines [3,2-a:2 ', 3 '-c] azophenlyene-11,12-imidazoles, with the mixed in molar ratio of 1:1, adds ethylene glycol, at argon shield and 120 ℃, reacts 6h, is chilled to room temperature, and thin up, adds NH 4pF 6saturated solution, obtains red precipitate, suction filtration, and water and ether washing precipitation, will precipitate and be dried, and with acetonitrile, dissolve, and use neutral alumina column chromatography for separation, by main red part under eluent wash-out, boil off solvent, obtain red powder for [Ru (phen) 2dppzi] (PF 6) 2product.
The concentration of the vitriol oil described in step 1) is 98%.
The weight percentage of the Pd in palladium-carbon catalyst step 2) is 5%.
RuCl in step 5) 3with the mol ratio of dipyridyl be 1:2, RuCl in step 6) 3with the mol ratio of phenanthroline be 1:2.
Eluent described in step 7) and step 8) is mixed and forms by the volume ratio of 1:3 by toluene and acetonitrile.
As telomere G-tetra-serobila DNA molecular photoswitches.
The telomere G-tetra-serobila DNA that described telomere G-tetra-serobila DNA are people.
Described telomere G-tetra-serobila DNA contain 22 Nucleotide.
The nucleotides sequence of described telomere G-tetra-serobila DNA is classified 5 '-AGGGTTAGGGTTAGGGTTAGGG-3 ' as, is called for short AG 3(T 2aG 3) 3.
Ruthenium in the present invention (II) multi-pyridine ligand has good G-tetra-serobila DNA molecular photoswitch performances; Can be used as G-tetra-serobila DNA molecular photoswitches.
Accompanying drawing explanation
Figure 1 shows that [Fe (CN) 6] 4-titration Ru-polypyridine complex [Ru (bpy) 2dppzi] 2+fluorescent quenching figure;
Figure 2 shows that G-tetra-serobila DNA titration Ru-polypyridine complex [Ru (bpy) 2dppzi] 2+the luminescent spectrum figure of the aqueous solution.
Embodiment
The preparation method of ruthenium of the present invention (II) multi-pyridine ligand, specifically comprises the following steps:
1, main part two pyridines [3,2-a:2 ', 3 '-c] azophenlyene-11, the preparation of 12-imidazoles (dppzi)
1) 5,6-dinitrobenzene benzo imidazoles synthetic
Under condition of ice bath, 2.0g5-nitrobenzimidazole and 30mL nitrosonitric acid are added in 250mL three-necked bottle, stir until dissolve completely, 98% the vitriol oil and the nitrosonitric acid (volume ratio is 1:1) that add again 15mL, at 110 ℃, stir 6h, add ice cube that reaction is stopped, the NaOH solution neutralization with 37%.Produce a large amount of faint yellow precipitations, filter, obtain thick product.With acetic acid ethyl dissolution, with silicagel column separated (ethyl acetate and toluene for eluent), obtain 5,6-dinitrobenzene benzo imidazoles.
2) 5,6-diamino benzo imidazoles synthetic
In 50mL three-necked bottle, add 2.08g(10mmol) 5,6-dinitrobenzene benzo imidazoles, 35ml ethanol and 5% palladium-carbon catalyst 0.25g; magnetic agitation; with separating funnel, drip 10mL hydrazine hydrate down nitrogen protection, frozen water are cooling, remove ice-water bath, be warming up to 40 ℃ and continue reaction 10h.Standing, filter, obtain red-brown clear solution, add gac, at 60-80 ℃, heated and stirred is 1 hour, and filtered while hot obtains colourless solution, and decompression is spin-dried for solvent, and with ethyl alcohol recrystallization, vacuum-drying, obtaining white plates crystal is 5,6-diamino benzo imidazoles.
3) phenanthroline-5,6-diketone synthetic
Mix and be placed in 4.0g phenanthroline and 4.0g Potassium Bromide thoroughly round-bottomed flask, then drip the mixing acid of the cold vitriol oil (40mL) and concentrated nitric acid (20mL).Drip after mixing acid, holding temperature is after 80-85 ℃ of reaction 3h, cooling.Be poured in 500mL frozen water, then with 10mol/L sodium hydroxide solution, be carefully neutralized to neutrality, with chloroform, solution is extracted.Merge after organic phase, wash with water.Finally with anhydrous sodium sulfate drying, spend the night.After filtration, decompression steams chloroform, solid product ethyl alcohol recrystallization, and obtaining yellow or orange-yellow needle-like crystal is phenanthroline-5,6-diketone.
4) main part is synthetic
By phenanthroline-5,6-diketone (0.42g, 2mmol), 5,6-diamino benzo imidazoles (0.30g, 2mmol) adds in three-necked bottle, adds 20ml methyl alcohol, reflux 2h, cooling, filter, by recrystallizing methanol, obtaining yellow crystals is main part two pyridines [3,2-a:2 ', 3 '-c] and azophenlyene-11,12-imidazoles (dppzi).
2. ruthenium (II) multi-pyridine ligand [Ru (bpy) 2dppzi] (PF 6) 2preparation
1) cis-[Ru (bpy) 2cl 2] .2H 2o's is synthetic
Take 1.56g (about 6mmol) RuCl 3.nH 2o, 1.87g(12mmol) dipyridyl (bpy) and 1.68g(28mmol) lithium chloride be placed in three-necked bottle, add 10ml DMF(N, dinethylformamide), reflux 8h under argon shield, is chilled to after room temperature, adds 50ml acetone, freeze overnight.Suction filtration, frozen water and cold washing with acetone several for precipitation, vacuum-drying, obtaining atropurpureus crystallite is cis-[Ru (bpy) 2cl 2] .2H 2o.
2) [Ru (bpy) 2dppzi] (PF 6) 2synthetic
Take 0.16g(0.3mmol) Cis-[Ru (bpy) 2cl 2] .2H 2o and 0.094g(0.3mmol) dppzi mixes, and adds 20mL ethylene glycol, at argon shield and 120 ℃, reacts 6h, is chilled to room temperature, adds the dilution of 50ml water, adds NH 4pF 6saturated solution, produces a large amount of red precipitates, suction filtration, and water and ether washing are for several times, dry.With acetonitrile, dissolve, with neutral alumina column separated (200 order).By main red part under toluene acetonitrile eluent (volume ratio 1:3) wash-out, boil off solvent, obtain red powder for [Ru (bpy) 2dppzi] (PF 6) 2product.
3.[Ru (phen) 2dppzi] (PF 6) 2preparation
1) cis-[Ru (phen) 2cl 2] .3H 2o's is synthetic
Take 1.56g (about 6mmol) RuCl 3.nH 2o, 2.40g(12mmol) phenanthroline (phen) and 1.68g(28mmol) lithium chloride in three-necked bottle, add 10mL DMF, reflux 8h under argon shield, is chilled to after room temperature, adds 50mL acetone, freeze overnight.Suction filtration, precipitation frozen water, cold washing with acetone several, vacuum-drying, obtaining atropurpureus crystallite is cis-[Ru (phen) 2cl 2] .3H 2o.
2) [Ru (phen) 2dppzi] (PF 6) 2synthetic
Take 0.17g(0.3mmol) cis-[Ru (phen) 2cl 2] .3H 2o and 0.094g(0.3mmol) dppzi mixes, and adds 20mL ethylene glycol, at argon shield and 120 ℃, reacts 6h, is chilled to room temperature, adds the dilution of 50mL water, adds NH 4pF 6saturated solution, produces a large amount of red precipitates, suction filtration, and water and ether washing are for several times, dry.With acetonitrile, dissolve, with neutral alumina column separated (200 order).By main red part under toluene acetonitrile eluent (volume ratio 1: 3) wash-out, boil off solvent, obtain red powder for [Ru (phen) 2dppzi] (PF 6) 2product.
Ruthenium of the present invention (II) multi-pyridine ligand, as the application of G-tetra-serobila DNA molecular photoswitches, is specifically implemented as follows:
One, the preparation of damping fluid:
Formulated by 10mM Tris and 100mM KCl, PH=7.0.
Two, the preparation of G-tetra-serobila DNA and title complex and concentration are determined
1) preparation of G-tetra-serobila DNA and concentration are determined
Get the rich G single stranded DNA (nucleotides sequence is classified 5 '-AGGGTTAGGGTTAGGGTTAGGG-3 ' as) of certain mass, be dissolved in damping fluid, be heated to seal to 90 ℃, and keep 5 minutes.Then naturally cool to room temperature, put into 4 ℃ of refrigerators and keep 24 hours, prepare G-tetra-serobila DNA.By its concentration of ultraviolet spectrometer measure and calculation.
[G]=K×A 260/228500(M)
In above formula, [G] represents the concentration of four serobila DNA, and K is extension rate.While measuring DNA absorbancy, as DNA excessive concentration, can cause absorbancy inaccurate, generally should be diluted to A and be advisable between 0.5-1.
2) preparation of title complex and concentration are determined
The preparation method of title complex is the same, and the concentration of title complex is calculated according to corresponding quality and molecular weight.
Three, title complex and the interactional fluorometric assay of G-tetra-serobila DNA
Sweep limit: 500-800nm, excitation wavelength: 450nm, slit width: (10,10), voltage: 500V.
Preparation Ru-polypyridine complex solution 5uM, with excited by visible light, observes luminous situation.Drip [the Fe (CN) of 100mM 6] 4-, make fluorescent quenching.With micro sample adding appliance, at every turn toward the G-tetra-serobila DNA storing solutions that add same volume in sample pool, concentration ratio [DNA]/[Ru] of G-tetra-serobila DNA and title complex increases by a certain percentage, until saturated.Mix after approximately 5 minutes, the fluorescence spectrum of observing at 500-800nm scope monitoring title complex changes with about 450nm light source activation, records utilizing emitted light crest and luminous intensity at every turn.
Result shows: G-tetra-serobilas add after Ru-polypyridine complex, and fluorescence significantly strengthens.
Figure 1 shows that [Fe (CN) 6] 4-titration Ru-polypyridine complex [Ru (bpy) 2dppzi] 2+fluorescent quenching figure;
Figure 2 shows that G-tetra-serobila DNA titration Ru-polypyridine complex [Ru (bpy) 2dppzi] 2+the luminescent spectrum figure of the aqueous solution.

Claims (10)

1. a ruthenium (II) multi-pyridine ligand, it is characterized in that: described ruthenium (II) multi-pyridine ligand is with two pyridines [3,2-a:2 ', 3 '-c] and azophenlyene-11,12-imidazoles is main part, using dipyridyl or phenanthroline as ruthenium (II) title complex of assistant ligand, and the chemical formula of this ruthenium (II) multi-pyridine ligand is [Ru (bpy) 2dppzi] (PF 6) 2or [Ru (phen) 2dppzi] (PF 6) 2, wherein, [Ru (bpy) 2dppzi] (PF 6) 2following (1) formula of structural formula shown in, [Ru (phen) 2dppzi] (PF 6) 2shown in following (2) formula of structural formula;
Bpy represents dipyridyl, and phen represents phenanthroline, and dppzi represents two pyridines [3,2-a:2 ', 3 '-c] azophenlyene-11,12-imidazoles.
2. the preparation method of ruthenium as claimed in claim 1 (II) multi-pyridine ligand, is characterized in that, comprises the following steps:
1) 5,6-dinitrobenzene benzo imidazoles synthetic
By 5-nitrobenzimidazole reacting by heating under the vitriol oil and nitrosonitric acid environment, cooling rear with sodium hydroxide neutralization, prepare 5,6-dinitrobenzene benzo imidazoles;
2) 5,6-diamino benzo imidazoles synthetic
By step 1) gained 5,6-dinitrobenzene benzo imidazoles is usingd palladium carbon as catalyzer, usings hydrazine hydrate as reductive agent, usings ethanol as solvent, under argon shield, reacts, and reaction product activated carbon decolorizing, filters, and prepares 5,6-diamino benzo imidazoles;
3) phenanthroline-5,6-diketone synthetic
With phenanthroline and Potassium Bromide, under the effect of vitriol oil concentrated nitric acid, prepare phenanthroline-5,6-diketone;
4) two pyridines [3,2-a:2 ', 3 '-c] azophenlyene-11, the main part of 12-imidazoles synthetic
By phenanthroline-5,6-diketone and 5,6-dinitrobenzene benzo imidazoles, with the mixed in molar ratio of 1:1, add methyl alcohol or ethanol as solvent, and reflux is prepared two pyridines [3,2-a:2 ', 3 '-c] azophenlyene-11, the main part of 12-imidazoles;
5) cis-[Ru (bpy) 2cl 2] 2H 2o's is synthetic
Use RuCl 3, dipyridyl and lithium chloride in DMF, reflux under argon shield, adds acetone after cooling, prepares cis-[Ru (bpy) 2cl 2] 2H 2o;
6) cis-[Ru (phen) 2cl 2] 3H 2o's is synthetic
Use RuCl 3, phenanthroline and lithium chloride in DMF, argon shield reflux, adds acetone after cooling, prepares cis-[Ru (phen) 2cl 2] 3H 2o;
7) [Ru (bpy) 2dppzi] (PF 6) 2synthetic
By cis-[Ru (bpy) 2cl 2] 2H 2o and two pyridines [3,2-a:2 ', 3 '-c] azophenlyene-11,12-imidazoles, with the mixed in molar ratio of 1:1, adds ethylene glycol, at argon shield and 120 ℃, reacts 6h, and cooling, thin up, adds NH 4pF 6saturated solution, obtains red precipitate, suction filtration, and water and ether washing precipitation, will precipitate and be dried, and with acetonitrile, dissolve, and use neutral alumina column chromatography for separation, by main red part under eluent wash-out, boil off solvent, obtain red powder for [Ru (bpy) 2dppzi] (PF 6) 2product;
8) [Ru (phen) 2dppzi] (PF 6) 2synthetic
By cis-[Ru (phen) 2cl 2] 3H 2o and two pyridines [3,2-a:2 ', 3 '-c] azophenlyene-11,12-imidazoles, with the mixed in molar ratio of 1:1, adds ethylene glycol, at argon shield and 120 ℃, reacts 6h, is chilled to room temperature, and thin up, adds NH 4pF 6saturated solution, obtains red precipitate, suction filtration, and water and ether washing precipitation, will precipitate and be dried, and with acetonitrile, dissolve, and use neutral alumina column chromatography for separation, by main red part under eluent wash-out, boil off solvent, obtain red powder for [Ru (phen) 2dppzi] (PF 6) 2product.
3. the preparation method of ruthenium as claimed in claim 2 (II) multi-pyridine ligand, is characterised in that: the concentration of the vitriol oil described in step 1) is 98%.
4. the preparation method of ruthenium as claimed in claim 2 (II) multi-pyridine ligand, is characterised in that: step 2) described in the weight percentage of Pd in palladium-carbon catalyst be 5%.
5. the preparation method of ruthenium as claimed in claim 2 (II) multi-pyridine ligand, is characterised in that: RuCl in step 5) 3with the mol ratio of dipyridyl be 1:2, RuCl in step 6) 3with the mol ratio of phenanthroline be 1:2.
6. the preparation method of ruthenium as claimed in claim 2 (II) multi-pyridine ligand, is characterised in that: the eluent described in step 7) and step 8) is mixed and forms by the volume ratio of 1:3 by toluene and acetonitrile.
7. the application of ruthenium as claimed in claim 1 (II) multi-pyridine ligand in preparing telomere G-tetra-serobila DNA molecular photoswitches.
8. the application of ruthenium as claimed in claim 7 (II) multi-pyridine ligand, is characterised in that: the telomere G-tetra-serobila DNA that described telomere G-tetra-serobila DNA are people.
9. the application of ruthenium as claimed in claim 8 (II) multi-pyridine ligand, is characterised in that: described telomere G-tetra-serobila DNA contain 22 Nucleotide.
10. the application of ruthenium as claimed in claim 7 (II) multi-pyridine ligand, is characterised in that: the nucleotides sequence of described telomere G-tetra-serobila DNA is classified 5 '-AGGGTTAGGGTTAGGGTTAGGG-3 ' as.
CN201010533717.4A 2010-11-05 2010-11-05 Ruthenium (II)-polypyridine complex, and preparation method and application thereof Expired - Fee Related CN102464676B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201010533717.4A CN102464676B (en) 2010-11-05 2010-11-05 Ruthenium (II)-polypyridine complex, and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201010533717.4A CN102464676B (en) 2010-11-05 2010-11-05 Ruthenium (II)-polypyridine complex, and preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN102464676A CN102464676A (en) 2012-05-23
CN102464676B true CN102464676B (en) 2014-03-05

Family

ID=46068834

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201010533717.4A Expired - Fee Related CN102464676B (en) 2010-11-05 2010-11-05 Ruthenium (II)-polypyridine complex, and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN102464676B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102731577B (en) * 2012-06-18 2014-12-24 广东药学院 Synthetic method for ruthenium metal complex
CN102924525B (en) * 2012-06-18 2015-01-07 广东药学院 Synthesis method for novel ruthenium (II) polypyridyl complex
CN103145760B (en) * 2012-12-27 2015-06-17 中国科学院上海硅酸盐研究所 Post-processing method of ruthenium complex reaction liquid and obtained ruthenium complex crude products
CN103739632A (en) * 2013-10-23 2014-04-23 江苏大学 Preparation method of cobalt metal organic complex having photocatalytic activity
CN104876968A (en) * 2015-04-28 2015-09-02 同济大学 Polypyridine chiral ruthenium (II) complex and preparation method and application thereof
CN105732723B (en) * 2016-03-18 2018-08-28 同济大学 A kind of ruthenium (II) multi-pyridine ligand and its preparation and application
CN105858734B (en) * 2016-03-20 2017-07-14 北京工业大学 Ru complexs Ru (bpy)3(NH2)2The method being combined with graphene quantum
CN107417736B (en) * 2017-07-26 2019-12-03 广东医科大学 A kind of ruthenium complex and its synthetic method and application
CN109456365B (en) * 2018-12-05 2020-09-25 湖南文理学院 Ruthenium complex fluorescent probe, preparation method and application
CN112724961B (en) * 2020-07-02 2022-07-01 中国人民解放军63653部队 Preparation method of white light emission carbon quantum dots

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1289775A (en) * 1999-09-24 2001-04-04 中国科学院化学研究所 Ruthenium (II) polypyridine match and its preparing process
US6306601B1 (en) * 1997-08-11 2001-10-23 The California Institute Of Technology Detection and treatment of duplex polynucleotide damage
CN1359901A (en) * 2000-12-21 2002-07-24 中国科学院感光化学研究所 Ru-polypyridine complex and its synthesizing process and use
US6440971B1 (en) * 1997-09-19 2002-08-27 A+ Science Invest Ab Binuclear complex
US20070082881A1 (en) * 2005-08-02 2007-04-12 Board Of Regents, The University Of Texas System Compounds with modifying activity enhanced under hypoxic conditions
CN1986555A (en) * 2006-12-15 2007-06-27 武汉大学 Preparing process of Ru(II) polypyridine complex
CN101555253A (en) * 2009-05-08 2009-10-14 中山大学 Ruthenium polypyridyl complex inducing DNA to condense, preparation method and application thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6306601B1 (en) * 1997-08-11 2001-10-23 The California Institute Of Technology Detection and treatment of duplex polynucleotide damage
US6440971B1 (en) * 1997-09-19 2002-08-27 A+ Science Invest Ab Binuclear complex
CN1289775A (en) * 1999-09-24 2001-04-04 中国科学院化学研究所 Ruthenium (II) polypyridine match and its preparing process
CN1359901A (en) * 2000-12-21 2002-07-24 中国科学院感光化学研究所 Ru-polypyridine complex and its synthesizing process and use
US20070082881A1 (en) * 2005-08-02 2007-04-12 Board Of Regents, The University Of Texas System Compounds with modifying activity enhanced under hypoxic conditions
CN1986555A (en) * 2006-12-15 2007-06-27 武汉大学 Preparing process of Ru(II) polypyridine complex
CN101555253A (en) * 2009-05-08 2009-10-14 中山大学 Ruthenium polypyridyl complex inducing DNA to condense, preparation method and application thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Shuo Shi等,.Electronic effect of different positions of the–NO2 group on the DNA-intercalator of chiral complexes [Ru(bpy)2L]2+ (L=o-npip,m-npip and p-npip).《Dalton Trans.》.2005,第2038-2046页. *
Shuo Shi等,.Molecular "light switch" for G-quadruplexes and i-motif of human telomeric DNA:[Ru(phen)2(dppz)]2+.《Dalton Transactions》.2010,第39卷第2490-2493页.
刘劲刚等,.多吡啶钌配合物作为DNA结构探针的研究.《无机化学学报》.2000,第16卷(第2期),第195-203页. *

Also Published As

Publication number Publication date
CN102464676A (en) 2012-05-23

Similar Documents

Publication Publication Date Title
CN102464676B (en) Ruthenium (II)-polypyridine complex, and preparation method and application thereof
Ramachandram et al. Unusually high fluorescence enhancement of some 1, 8-naphthalimide derivatives induced by transition metal salts
Lo et al. Synthesis, structures and luminescent properties of new heterobimetallic Zn-4f Schiff base complexes
Sivakumar et al. Synthesis and crystal structures of lanthanide 4-benzyloxy benzoates: Influence of electron-withdrawing and electron-donating groups on luminescent properties
Pascu et al. Dinuclear ruthenium (II) triple‐stranded helicates: luminescent supramolecular cylinders that bind and coil DNA and exhibit activity against cancer cell lines
Sheet et al. Aggregation-induced emission-active ruthenium (II) complex of 4, 7-dichloro phenanthroline for selective luminescent detection and ribosomal RNA imaging
EP2868661B1 (en) Bipyridyl triazole rare earth complex and preparation process therefor
CN102276481B (en) Calixarene derivative and metal complex thereof, and preparation method and application of calixarene derivative and metal complex thereof
Tsai et al. Luminescent Zn (ii) coordination polymers as efficient fluorescent sensors for highly sensitive detection of explosive nitroaromatics
George et al. Near-infrared luminescence of Nd 3+ and Yb 3+ complexes using a polyfluorinated pyrene-based β-diketonate ligand
CN106318380B (en) A kind of tetraphenylethylene derivative ionic complex and preparation method
Verma et al. Photophysical properties of ligand localized excited state in ruthenium (ii) polypyridyl complexes: A combined effect of electron donor–acceptor ligand
Saha et al. Structural characterization and spectroelectrochemical, anion sensing and solvent dependence photophysical studies of a bimetallic Ru (ii) complex derived from 1, 3-di (1 H-imidazo [4, 5-f][1, 10] phenanthroline-2-yl) benzene
CN104804728A (en) Preparation and application of fluorescence-enhanced thiophenol fluorescence probe
CN102924524A (en) Manganese complex two-photon absorption material with living cell developing function and synthesis method thereof
CN103896972A (en) Method for preparing chiral dual-core europium beta-diketone complex luminescent material
CN103724329A (en) Preparation method of 4-[5-(pyridyl-4-yl)-1H-[1,2,4]triazolyl-3-yl]pyridyl-2-formonitrile
CN103467388A (en) Method for synthesizing aryl or heteroaryl substituted quinazoline compound
Wang et al. Different structures modulated mechanochromism and aggregation-induced emission in a series of Gold (I) complexes
Ho et al. The synthesis and photophysical studies of cyclometalated Pt (ii) complexes with C, N, N-ligands containing imidazolyl donors
CN105418534A (en) Azo-furazan compound and preparing method thereof
CN102002001B (en) 2, 2' - (1, 4-phenylene) di (benzimidazole-5-carboxylic acid) and preparation method thereof
CN110746423A (en) Synthesis of aryl imidazophenanthroline fluorescent dye and identification of metal ions
CN105294540A (en) Novel Schiff base compound taking triphenylamine as center and preparation of novel Schiff base compound
CN102964366A (en) Rare earth complex with aggregation-induced fluorescence enhancement effect, probe and preparation method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140305

Termination date: 20161105

CF01 Termination of patent right due to non-payment of annual fee